Table of Contents Table of Contents
Previous Page  109 128 Next Page
Information
Show Menu
Previous Page 109 128 Next Page
Page Background

0

1

2

3

4

5

6

7

8

9

0

0.5

1

1.5

2

2.5

3

none

forsk

none

forsk

none

forsk

none

forsk

none

forsk

none

forsk

none

forsk

none

forsk

0

0.5

1

1.5

2

2.5

3

3.5

4

0

0.2

0.4

0.6

0.8

1

1.2

LG

HG

LG

HG

LG

HG

LG

HG

LG

HG

LG

HG

LG

HG

LG

HG

A

JUNB FOS FOSB

**

*

*

wt

CDKAL1

-/-

EGR3

FOSB

EGR2

KRT5

FOS

LHX5

EGR1

CXCL14

DUSP1

CYP26C1

NR4A1

TWIST2

CYP26A1

HIST4H4

CRYBA2

G6PC2

JUN

1

3

5

7

9

E

22.2

23.9

60.5

Annexin V

wt

CDKAL1

-/-

ctrl-p palmitate ctrl-p palmitate

40.9

% of Annexin V

+

cells

in INS-GFP

+

cells

Relative mRNA

expression

Fold Change

wt

CDKAL1

-/-

B

Fold Change

*

**

n.s.

n.s.

**

n.s.

wt

CDKAL1

-/-

J

K

wt

CDKAL1

-/-

scramble sgRNA

sgFOS

sgRNA sgFOS sgRNA sgFOS

scramble scamble

F

FOS

GAPDH

wt

CDKAL1

-/-

41 kDa

37 kDa

Color

−1

0 0.5 1 Value

Key

0

0.5

1

1.5

2

2.5

3

3.5

4

0

1

2

3

4

5

6

7

8

0

1

2

3

4

5

6

0

0.5

1

1.5

2

Systemic lupus erythematosus

GnRH signaling pathway

ECM-receptor interaction

Pathways in cancer

B cell receptor signaling pathway

Neuroactive ligand-receptor interaction

Epithelial cell signaling inHelicobacter

pylori infection

Vibrio cholerae infection

MAPK signaling pathway

Complementand coagulation cascades

Focal adhesion

cFOS/JUN

- log P-value

D

1 2 1 2 1 2 1 2

*

**

** **

n.s.

Human c-peptide (% of content)

1 2 1 2 1 2 1 2

Fold Change

**

**

n.s.

n.s.

***

n.s.

wt

CDKAL1

-/-

wt

CDKAL1

-/-

scramble sgRNA

sgFOS

sgRNA sgFOS sgRNA sgFOS

scramble scamble

1 2 1 2 1 2 1 2

**

**

** **

n.s.

Human c-peptide (% of content)

1 2 1 2 1 2 1 2

H

sgFOS2 sgFOS1 scramble sgRNA2 scramble sgRNA1

wt

CDKAL1

-/-

7AAD

ctrl-g high glucose ctrl-g high glucose

19.2 40.1 18.3 55.3

18.2 39.6 18.5 42.7

18.0 40.8 18.4 55.2

18.9 40.6 18.0 44.5

0

10

20

30

40

50

60

70

1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2

ctrl-g glu ctrl-g glu ctrl-p palm ctrl-p palm

wt

CDKAL1

-/-

wt

CDKAL1

-/-

scramble sgRNA sgFOS

n.s.

n.s.

n.s.

**

n.s.

n.s.

n.s.

***

42.3

24.2

46.0

22.9

19.1 40.4 20.5 61.9

19.2 40.9 20.2 44.5

wt

CDKAL1

-/-

C

G

I

0

5

10

15

20

25

30

35

40

45

% of PI

+

INS

+

cells

in INS

+

cells

1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2

ctrl-g glu ctrl-g glu ctrl-p palm ctrl-p palm

wt

CDKAL1

-/-

wt

CDKAL1

-/-

scramble sgRNA sgFOS

n.s.

n.s.

n.s.

**

n.s.

n.s.

n.s.

**

Focal Adhesion

cFOS/JUN

ACTG2

(legend on next page)

Cell Stem Cell

19

, 326–340, September 1, 2016

335